- Home
- GDTC vs GENK Comparison
GDTC vs GENK Comparison
Compare GDTC & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- GENK
- Stock Information
- Founded
- GDTC 2018
- GENK 2011
- Country
- GDTC Singapore
- GENK United States
- Employees
- GDTC N/A
- GENK N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- GDTC Health Care
- GENK Consumer Discretionary
- Exchange
- GDTC Nasdaq
- GENK Nasdaq
- Market Cap
- GDTC 22.9M
- GENK 20.4M
- IPO Year
- GDTC 2023
- GENK 2023
- Fundamental
- Price
- GDTC $1.90
- GENK $3.16
- Analyst Decision
- GDTC Buy
- GENK Strong Buy
- Analyst Count
- GDTC 1
- GENK 2
- Target Price
- GDTC $5.00
- GENK $7.00
- AVG Volume (30 Days)
- GDTC 9.9K
- GENK 66.8K
- Earning Date
- GDTC 01-01-0001
- GENK 08-06-2025
- Dividend Yield
- GDTC N/A
- GENK 3.80%
- EPS Growth
- GDTC N/A
- GENK N/A
- EPS
- GDTC N/A
- GENK N/A
- Revenue
- GDTC $368,838.00
- GENK $216,137,000.00
- Revenue This Year
- GDTC $5.37
- GENK $12.35
- Revenue Next Year
- GDTC N/A
- GENK $14.62
- P/E Ratio
- GDTC N/A
- GENK N/A
- Revenue Growth
- GDTC N/A
- GENK 10.67
- 52 Week Low
- GDTC $1.20
- GENK $3.12
- 52 Week High
- GDTC $4.05
- GENK $10.33
- Technical
- Relative Strength Index (RSI)
- GDTC 48.17
- GENK 36.62
- Support Level
- GDTC $1.85
- GENK $3.15
- Resistance Level
- GDTC $2.07
- GENK $3.39
- Average True Range (ATR)
- GDTC 0.08
- GENK 0.15
- MACD
- GDTC 0.02
- GENK 0.00
- Stochastic Oscillator
- GDTC 51.12
- GENK 10.31
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.